Welcome to our dedicated page for Figs news (Ticker: FIGS), a resource for investors and traders seeking the latest updates and insights on Figs stock.
FIGS Inc (FIGS) delivers innovative medical apparel through advanced fabric technology and a vertically integrated digital platform. This resource provides investors and healthcare professionals with centralized access to official company announcements and verified news developments.
Track FIGS' strategic initiatives including technical textile advancements, e-commerce platform enhancements, and healthcare sector partnerships. Our aggregation includes earnings disclosures, product line expansions, and operational updates directly affecting the medical apparel market.
Key focus areas mirror FIGS' corporate priorities: antimicrobial fabric research, direct-to-consumer sales metrics, and sustainable manufacturing processes. Users receive timely updates on scrubs market positioning and digital retail innovations without promotional bias.
Bookmark this page for efficient monitoring of FIGS' market movements, including regulatory filings and leadership changes. Combine quarterly financial results with product innovation timelines for comprehensive analysis of this healthcare apparel innovator.
FIGS, Inc. (NYSE: FIGS) announced its participation in a fireside chat at the 24th Annual ICR Conference on January 10, 2022, at 2:00 PM EST. The Co-CEOs, Heather Hasson and Trina Spear, along with CFO Daniella Turenshine, will engage in this discussion. The chat will be accessible via live webcast and will be archived for 90 days. FIGS is known for its direct-to-consumer healthcare apparel brand that focuses on providing comfort, durability, and style to healthcare professionals through its digital platform.
FIGS, Inc. (NYSE: FIGS) announced the retirement of CFO Jeffrey Lawrence, effective December 24, 2021. Daniella Turenshine, previously Senior VP of Finance and Strategy, will succeed him. Under her leadership, FIGS has achieved significant revenue growth and profitability. Lawrence praised the company’s IPO success and expressed confidence in Turenshine’s capabilities. Both executives highlighted a commitment to the healthcare community and the company’s future growth. The transition reflects FIGS' strategic direction as it continues to innovate in the healthcare apparel sector.
FIGS, Inc. (NYSE: FIGS) reported its third-quarter 2021 financial results, raising its full-year revenue outlook to $410 million, up from $395 million. The company continues to focus on providing advanced healthcare apparel to professionals through its direct-to-consumer model. A conference call is scheduled for November 10, 2021, at 2:00 p.m. PT to discuss these results and the business outlook.
FIGS, Inc. (NYSE: FIGS) has announced a new shareholder Q&A platform to facilitate interaction before its Q3 2021 earnings conference call, scheduled for November 10, 2021, at 2:00 p.m. PT / 5:00 p.m. ET. Shareholders can submit and upvote questions via the Say platform until November 9, 2021.
This initiative aims to enhance shareholder engagement and improve transparency around financial and business results.
FIGS, Inc. (NYSE: FIGS) announced it will release its third quarter 2021 results on November 10, 2021, after U.S. markets close. This will be followed by a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss the financial outcomes and future outlook. The press release will include a link to a shareholder letter and detailed financial results available on their investor relations website. Investors can access the live call and replay options for further insights.
FIGS, Inc. (NYSE: FIGS) has announced the pricing of a secondary offering of 8,917,385 shares of its Class A common stock at $40.25 per share, led by its largest stockholder, Tulco, LLC. The underwriters hold a 30-day option for an additional 1,337,607 shares. FIGS will not receive proceeds from this sale, which is expected to close on September 20, 2021, pending customary conditions. Major underwriters include Goldman Sachs, Morgan Stanley, and Barclays Capital.
FIGS, Inc. (NYSE: FIGS) announced a secondary offering of 8,826,703 shares of Class A common stock by its largest stockholder, Tulco, LLC, and certain management members. The underwriters have a 30-day option to purchase an additional 1,324,005 shares. FIGS will not receive any proceeds from this sale. The offering will be managed by major financial institutions, ensuring proper facilitation. This registration statement has been filed with the U.S. Securities and Exchange Commission; however, sales cannot occur until it becomes effective.
FIGS, Inc. (NYSE: FIGS) reported Q2 2021 net revenues of $101.1 million, a 57.6% increase from Q2 2020, driven by higher order volumes and average order values. Active customers grew by 79.2% to 1.6 million. Despite this growth, the company faced a net loss of $40.5 million, largely attributed to stock-based compensation costs from its IPO. Adjusted EBITDA rose 54.5% to $26.8 million, with a margin of 26.5%. Looking forward, FIGS forecasts 2021 net revenues of approximately $395 million.
FIGS, Inc. (NYSE: FIGS) will release its Q2 2021 financial results on August 12, 2021, post-market close. A conference call is scheduled for 1:30 p.m. PT / 4:30 p.m. ET to discuss the results and business outlook. Investors can join the live call at (866) 211-4956 for US participants or (873) 415-0263 for international participants. The replay will be available until August 19, 2021. FIGS, a direct-to-consumer healthcare apparel brand, aims to enhance the experience of healthcare professionals through durable and stylish apparel.